Research Projects

Medical diagnosis is currently undergoing a major revolution due to the fast discovery of molecular biomarkers, and the development of multimodal “metabiomarker” signatures. Progress, however, is hindered by low abundance of many biomarkers of interest in body fluids, in absolute concentration and with regard to other biomolecules. The aim of the...

NanoNeuroOmics ambition is to bring together nanotechnology, proteomics and blood biomarker discovery at the emerging intersection of neurodegeneration and neurooncology. NanoNeuroOmics proposes a nanotechnology-based innovative solution for the integrative profiling of the blood and brain tissue proteomes to address two interconnected challenges...

Background: There has been great interest in identifying persons at high risk of developing Alzheimer disease (AD) and dementia, as they should constitute a target group for possible prevention or early treatment of dementia in the future. Mild Cognitive Impairment (MCI) is a transitional zone between normal cognitive function and clinical AD. The...

Your brain is among the most complex existing systems, and it processes every second an amazing amount of data. The most amazing thing, however, is that you get to know some of it. Declarative knowledge, meaning the portion of knowledge that we can consciously access and manipulate, is one of the most enduring mysteries of the human mind. How did...

Age related memory decline, mild cognitive impairments (MCI), and cognitive impairments that occur with diseases, such as stroke, brain injuries, or early stages of dementia, have negative effects on the ability to navigate and to orient. Affected people who repeatedly start experiencing disorientation events often become scared of venturing out...

Alzheimers disease (AD) is a neurodegenerative disease affecting the aged population and is projected to increase 3-fold in the next 30 years. Treatment options in AD are limited due to complex pathological processes and the blood-brain barrier (BBB), which restrict entry molecules into the brain. A finding in AD is the loss of cholinergic neurons...

Alzheimer’s disease (AD) is a highly prevalent neurodegenerative disease associated with gradual loss of cognitive functions and brain vitality. The leading “amyloid cascade” hypothesis for the pathogenesis of AD states that amyloid-β (Aβ) starts to accumulate ~15 years before symptom onset and starts a cascade of pathological events, including...

Alzheimer’s disease (AD) has far-reaching societal and economic consequences, emphasizing the urgent need for effective treatment solutions. However, to date, over 99% of AD clinical trials have failed. Inadequate patient stratification is a key contributing factor due to the enormous clinical and pathological heterogeneity in AD. AD is...

The goal of the proposal is to identify the association of different narrative perseverations features in mild cognitive impairment (MCI) subtypes with their neural oscillatory profiles. MCI patients show moderately impaired performance on neuropsychological tests but relatively intact global cognition and daily functioning. Validated as different...

The entorhinal cortex contains grid cells, a major cell type underlying spatial navigation. At the same time, it is amongst the first areas of the brain to be affected by Alzheimer’s disease (AD). In humans, grid cell-like representations (GCLRs) have been proposed as a network-level signature of grid cells that can be recorded non-invasively via...

The MEMOLOAD project will focus on the molecular and biological mechanisms underlying memory loss that occurs in Alzheimer’s disease, the leading cause of dementia and an enormous medical, social and economic challenge to Europe. Several lines of evidence point to accumulation of beta-amyloid peptide (Aß) in the brain as the key pathologic event in...

The need: Today, although over 6M people suffer from Parkinson's and related diseases worldwide we have no objective early diagnostic test. By the time patients present the symptoms that lead to diagnosis the disease is already very advanced and the options for treatment extremely limited. This has an enormous impact on cost of care and an even...